Rejuvenate Biomed is gearing up to make a splash at #BioEquityEurope Conference in the beautiful San Sebastián on May 12-14. Dr Ann Beliën, Founder & CEO, is taking center stage and will unveil the exciting muscle strength data from our latest clinical trial on Tuesday May 14th, at 2pm, in room 6 7. We're eager to collaborate and explore funding opportunities. Share your interest and book a one-on-one meeting for a fruitful exchange of ideas and insights. Let's shape the future of healthcare together! 🤝 See you there! #musclestrength #clinicaltrial #biotech #funding
Rejuvenate Biomed’s Post
More Relevant Posts
-
Unlocking Time's Value in Drug Development: A Strategic Paradigm . In the intricate tapestry of drug development, time isn't just a fleeting resource—it's a priceless currency that holds the power to redefine the trajectory of medicine. Imagine harnessing time as a strategic asset, amplifying impact, and paving the way for revolutionary solutions. With Ubuntu, you can explore the idea of crafting time value and reshape the landscape of medical advancement. . . . #biotech #venturecapitalists #biotechnology #celltherapy #clinicalresearch #patientcentricity #drugdevsubscription #ubuntu #ubunturesearch
-
-
April 10 at 6pm PT. We have another incredible Innovator’s Workbench event planned, featuring Ted W. Love, MD, chair of the board of the Biotechnology Innovation Organization. Innovation Fellowship alum Uday Kumar, a senior advisor at Stanford Biodesign, will chat with Dr. Love about his journey into biotechnology innovation and the need to take on large, complex challenges to drive greater health equity for all populations. Don’t miss it! Registration link in the comments. #innovationeducation #biotech #healthtech #healthequity
-
-
Advances in life science research can lead to the development of novel technologies, which, in turn, have the potential to address unmet medical needs and to transform patient care. FUJIFILM is fully aware of the significance of innovative biotechnological research to advance healthcare. This is why, in 2022, FUJIFILM’s President, Representative Director, and CEO Teiichi Goto announced the launch of a Life Sciences Strategic Investment Fund focused on innovative emerging biotechnological companies. Learn all about FUJIFILM’s Life Sciences Strategic Investment Fund and how it accelerates cutting-edge biotech research: https://loom.ly/4XeV2hI #noveltechnologies #biotechnologicalresearch #biotech #biotechnology #healthcare #lifescience #medicalinnovation
-
Link to an informative write up, co authored by OMAPiX colleagues. The article provides details on identifying crucial insights using spatial multi modal analysis. OMAPIX has a team with domain expertise in ‘spatial omics' technologies scalable to support clinical decision making. With several active programs integrating these technologies with unique computation tools, we can collaborate to generate the right strategy for in depth analysis of drug MOA and disease characterization. Talkto us about how we can support your programs to advance your pipe line of assets and scale successfully to the clinic.
OMAPiX is proud to be a part of the scTrends consortium initiated by Adam Cribbs of Caeruleus Genomics and Jake P. Taylor-King of Relation. The consortium is excited to announce the publication of a comment piece in Nature Biotechnology of Nature Portfolio. As the #singlecell and #spatial technologies are evolving and maturing, the commercial technologies offer a breadth of choices. The consortium, in this commentary, has aimed to provide a brief overview of the established platforms, sketch out market dynamics, and contemplate on how technologies may differentiate themselves. Benedikt Nilges and Nachiket Kashikar from OMAPiX had a fun time working on this article, particularly on spatial technologies. We are confident that these technologies will transform the way we understand biology and provide impactful insights that will pave way for new diagnostics and therapies. https://lnkd.in/eTEZ_y6J
-
SFBN Feed: Gladstone’s Deepak Srivastava is using collabortion to propel medical research https://lnkd.in/gQPuVerz Gladstone Institutes’ Deepak Srivastava is bringing people together and propelling new medical research. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News
Gladstone’s Deepak Srivastava is using collabortion to propel medical research
https://sfbn.org
-
Science for health 2023 will be featuring a round table discussion on how Belgium can become a world biotechnology leader. Focusing on key technologies like ATMP, digital health, and radiotherapy, the panel delves into challenges, opportunities, and best practices. Have we sparked your interest? Register today: https://lnkd.in/e7pK8vCe #sfh2023 #biotech #lifesciences #biologymeetstechnology
-
-
We are excited to present our latest interview with Charlotte Broennimann, Product Manager at SEED Biosciences, showcasing their innovative Dispen3D technology. This groundbreaking product is set to transform single-particle isolation and dispensing, offering unparalleled precision and efficiency for researchers. Charlotte shares how Dispen3D is setting new standards in single-cell biology, driving advancements in drug discovery, personalized medicine, and regenerative therapies. Here are some key highlights: 🔬 Advanced Precision: Dispen3D enables high-precision experiments, crucial for cutting-edge research. 🌱 Biodegradable and Efficient: Utilizing magnetic chitosan, Dispen3D emphasizes environmental friendliness while enhancing research outcomes. ⚙️ Seamless Integration: Compatible with existing lab equipment, ensuring smooth adoption without overhauls. 🧬 Automation Benefits: Reduces human error and ensures reproducibility, saving time and resources. 💡 Transformative Impact: Case studies reveal significant improvements in drug screening and personalized medicine applications. Discover the key benefits and transformative potential of Dispen3D in improving research outcomes and laboratory workflows. 🔗Read the interview here: https://lnkd.in/ey6SiHXv #Innovation #Biotechnology #CellCulture #DrugDiscovery #PersonalizedMedicine #RegenerativeTherapies #Research #Dispen3D #SEEDBiosciences #LabTech #ScientificAdvancement
-
-
Strategic Partnerships, Protein expression, Purification and Characterization / Nanobody Discovery and Characterization/ Biochemistry / Biophysics / Structural Biology Analysis / Phage Display
𝗠𝗮𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗜𝗺𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲 𝗣𝗼𝘀𝘀𝗶𝗯𝗹𝗲 💡 We at Cube Biotech are thrilled to announce our latest copolymers addition to the NativeMP Platform. This platform is an essential tool to enable drug discovery on protein targets in their physiological state. 🌟 Why it matters: 🔬 **Physiologically Relevant Results**: Advanced #copolymers ensure results that reflect real biological conditions. 💊 **Bench to Bedside**: Our insights are more easily translatable, bridging the gap between research and patient care. 🌐 **Impact on Healthcare**: Develop therapies faster and with greater precision, improving patient outcomes. Help "US" help "YOU" save lives by pushing the boundaries of #membraneprotein science and #drugdiscovery. 📅 **Interested in learning more?** [Book a meeting with me here] https://lnkd.in/gnd5Ew3P. #Innovation #Science #Healthcare #Biotech #Pharma #MedicalResearch #Technology #Research Together, let's make the impossible possible! 🌍✨
-
-
Enabling labs and industries with tech, driving practical innovation. Bridging needs to manufacturers and developers for precise, impactful solutions. Let's shape the future together.
Exciting on-site visits to leading Biobanks, including Charité and the University Hospital Dresden, provided precious insights into the 'gold of the 21st century.' Rounded off the journey with a stop at the EU-OPENSCREEN compound library in Berlin. EU-OPENSCREEN integrates high-capacity screening platforms throughout Europe 🌱💼 #Biobanking #Research #CharitéBerlin #UniversityHospitalDresden #EUOPENSCREEN This hands-on experience lays a solid foundation for our crafting user-centric #WhitePapers and #ApplicationNotes tailored to our clients' needs. 💡📝 #LifeSciences #Biotech"
-
